Continuous positive airway pressure (CPAP) appears to be slightly better than intubation for reducing the risk of bronchopulmonary dysplasia in very preterm infants receiving breathing support for respiratory distress syndrome.
Authors of the study concluded that for every 25 babies treated with nasal CPAP rather than being intubated, 1 additional infant could survive to 36 weeks without developing bronchopulmonary dysplasia. They based their conclusion on a meta-analysis of 4 randomized controlled trials involving 2782 preterm infants needing respiratory support. Nearly all infants born before 28 weeks of pregnancy develop respiratory distress syndrome.
From JAMA’s Daily News Site. JAMA. 2014;311(3):234. doi:10.1001/jama.2013.285703
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: